Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bodil Vistisen
Sarcolemmal FAT/CD36 in Human Skeletal Muscle Colocalizes With Caveolin-3 and Is More Abundant in Type 1 Than in Type 2 Fibers
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Attenuated Gastric Distress but No Benefit to Performance With Adaptation to Octanoate-Rich Esterified Oils in Well-Trained Male Cyclists
Journal of Applied Physiology
Medicine
Physiology
Sports Science
Related publications
Isomyosins in Human Type 1 and Type 2 Skeletal Muscle Fibres
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Vitamin D Deficiency Is More Common in Type 2 Than in Type 1 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Arpp, a New Homolog of Carp, Is Preferentially Expressed in Type 1 Skeletal Muscle Fibers and Is Markedly Induced by Denervation
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Dietary Α-Linolenic Acid Supplementation Alters Skeletal Muscle Plasma Membrane Lipid Composition, Sarcolemmal FAT/CD36 Abundance, and Palmitate Transport Rates
American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
Acute Effects of Taurine on Sarcoplasmic Reticulum Ca2+ Accumulation and Contractility in Human Type I and Type II Skeletal Muscle Fibers
Journal of Applied Physiology
Medicine
Physiology
Sports Science
Skeletal Muscle Mass to Visceral Fat Area Ratio Is an Important Determinant Associated With Type 2 Diabetes and Metabolic Syndrome
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Gene Expression Profile in Human Skeletal Muscle Cells Infected With Human Adenovirus Type 36
Journal of Medical Virology
Virology
Infectious Diseases
Increased Mitochondrial Substrate Sensitivity in Skeletal Muscle of Patients With Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cabozantinib Is More Effective Than Erlotinib in EGFR –Wild-Type NSCLC
Cancer Discovery
Oncology